Thymosin Alpha 1: What Does It Do?
Summary
Host John Garrett examines thymocin alpha-1, clarifying it as an immune modulator rather than a booster. He details its mechanisms involving dendritic cells and T-cells, reviewing clinical data for hepatitis, cancer, and sepsis. The episode concludes that evidence does not support routine use for healthy individuals, emphasizing its lack of FDA approval and indication-specific benefits.
Topics discussed
Sponsors and webinar announcement
Introduction to Thymocin alpha-1
Mechanism of action and immune modulation
Clinical studies and sepsis trial results
Does it boost immunity in healthy people?
Regulatory status, risks, and safety
Recap and conclusion
Outro and final advertisements
Listen ad-free on Castria